Samara, M.; Papathanassiou, M.; Farmakioti, I.; Anagnostou, M.; Satra, M.; Mitrakas, L.; Anastasiou, D.; Chasiotis, G.; Christopoulos, A.; Anagnostou, A.;
et al. Renin-Angiotensin System Single Nucleotide Polymorphisms Are Associated with Bladder Cancer Risk. Curr. Oncol. 2021, 28, 4702-4708.
https://doi.org/10.3390/curroncol28060396
AMA Style
Samara M, Papathanassiou M, Farmakioti I, Anagnostou M, Satra M, Mitrakas L, Anastasiou D, Chasiotis G, Christopoulos A, Anagnostou A,
et al. Renin-Angiotensin System Single Nucleotide Polymorphisms Are Associated with Bladder Cancer Risk. Current Oncology. 2021; 28(6):4702-4708.
https://doi.org/10.3390/curroncol28060396
Chicago/Turabian Style
Samara, Maria, Maria Papathanassiou, Ioanna Farmakioti, Maria Anagnostou, Maria Satra, Lampros Mitrakas, Dimitrios Anastasiou, Georgios Chasiotis, Agamemnon Christopoulos, Athanasios Anagnostou,
and et al. 2021. "Renin-Angiotensin System Single Nucleotide Polymorphisms Are Associated with Bladder Cancer Risk" Current Oncology 28, no. 6: 4702-4708.
https://doi.org/10.3390/curroncol28060396
APA Style
Samara, M., Papathanassiou, M., Farmakioti, I., Anagnostou, M., Satra, M., Mitrakas, L., Anastasiou, D., Chasiotis, G., Christopoulos, A., Anagnostou, A., Christodoulou, A., Daponte, A., Ioannou, M., Koukoulis, G., Tzortzis, V., & Vlachostergios, P. J.
(2021). Renin-Angiotensin System Single Nucleotide Polymorphisms Are Associated with Bladder Cancer Risk. Current Oncology, 28(6), 4702-4708.
https://doi.org/10.3390/curroncol28060396
